Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Semrock

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Originally published in Science Express on 28 February 2008
Science 21 March 2008:
Vol. 319. no. 5870, pp. 1668 - 1672
DOI: 10.1126/science.1154584

Reports

TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis

Jemeen Sreedharan,1* Ian P. Blair,3,4* Vineeta B. Tripathi,1* Xun Hu,1 Caroline Vance,1 Boris Rogelj,1 Steven Ackerley,1,2 Jennifer C. Durnall,3 Kelly L. Williams,3 Emanuele Buratti,5 Francisco Baralle,5 Jacqueline de Belleroche,6 J. Douglas Mitchell,7 P. Nigel Leigh,1 Ammar Al-Chalabi,1 Christopher C. Miller,1,2 Garth Nicholson,3,4,8* Christopher E. Shaw1*{dagger}

Amyotrophic lateral sclerosis (ALS) is a fatal motor neuron disorder characterized pathologically by ubiquitinated TAR DNA binding protein (TDP-43) inclusions. The function of TDP-43 in the nervous system is uncertain, and a mechanistic role in neurodegeneration remains speculative. We identified neighboring mutations in a highly conserved region of TARDBP in sporadic and familial ALS cases. TARDBPM337V segregated with disease within one kindred and a genome-wide scan confirmed that linkage was restricted to chromosome 1p36, which contains the TARDBP locus. Mutant forms of TDP-43 fragmented in vitro more readily than wild type and, in vivo, caused neural apoptosis and developmental delay in the chick embryo. Our evidence suggests a pathophysiological link between TDP-43 and ALS.

1 Department of Clinical Neuroscience, King's College London, Medical Research Council (MRC) Centre for Neurodegeneration Research, and Institute of Psychiatry, London, SE5 8AF, UK.
2 Department of Neuroscience, King's College London, MRC Centre for Neurodegeneration Research, and Institute of Psychiatry, London, SE5 8AF, UK.
3 Northcott Neuroscience Laboratory, Australian and New Zealand Army Corps (ANZAC) Research Institute, Concord, NSW, 2137, Australia.
4 Faculty of Medicine, University of Sydney, Sydney, NSW, 2139, Australia.
5 International Centre for Genetic Engineering and Biotechnology, Padriciano 99, 34012 Trieste, Italy.
6 Division of Neurosciences and Mental Health, Faculty of Medicine, Imperial College London, and Charing Cross Hospital, London, W6 8RF, UK.
7 Department of Neurology, Royal Preston Hospital, Preston, PR2 9HT, UK.
8 Molecular Medicine Laboratory, Concord Repatriation General Hospital, Concord, NSW, 2139, Australia.

* These authors contributed equally to this work.

{dagger} To whom correspondence should be addressed. E-mail: chris.shaw{at}iop.kcl.ac.uk

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Evidence of Multisystem Disorder in Whole-Brain Map of Pathological TDP-43 in Amyotrophic Lateral Sclerosis.
F. Geser, N. J. Brandmeir, L. K. Kwong, M. Martinez-Lage, L. Elman, L. McCluskey, S. X. Xie, V. M.-Y. Lee, and J. Q. Trojanowski (2008)
Arch Neurol 65, 636-641
   Abstract »    Full Text »    PDF »
A yeast TDP-43 proteinopathy model: Exploring the molecular determinants of TDP-43 aggregation and cellular toxicity.
B. S. Johnson, J. M. McCaffery, S. Lindquist, and A. D. Gitler (2008)
PNAS 105, 6439-6444
   Abstract »    Full Text »    PDF »



ADVERTISEMENT
Click Me!

ADVERTISEMENT

To Advertise     Find Products